Table 2.
Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
Age | 1.080 (1.019–1.145) | 0.009 | 1.024 (0.936–1.121) | 0.600 |
Disease duration | 1.178 (1.037–1.338) | 0.012 | 1.159 (0.989–1.357) | 0.068 |
UPDRS-III (OFF) | 1.025 (0.995–1.056) | 0.107 | 0.995 (0.951–1.042) | 0.837 |
ePVS-CSO severity | 0.003 | 0.048 | ||
None/mild | 1(Ref) | 1(Ref) | ||
Moderate | 3.102 (0.920–10.458) | 0.068 | 3.305 (0.842–12.967) | 0.087 |
Severe | 5.328 (1.975–14.321) | 0.001 | 3.869 (1.213–12.339) | 0.022 |
ePVS-BG severity | 0.018 | 0.543 | ||
None/mild | 1(Ref) | 1(Ref) | ||
Moderate | 5.357 (1.485–19.332) | 0.010 | 2.240 (0.492–10.186) | 0.297 |
Severe | 2.857 (0.785–10.396) | 0.111 | 1.591 (0.344–7.354) | 0.552 |
OR, odds ratio; CI, confidence interval; Ref, reference; MoCA, Montreal Cognitive Assessment; ePVS, enlarged perivascular spaces; CSO, centrum semiovale; BG, basal ganglia; WMH, white matter hyperintensity.
The bold font indicates that the difference achieved statistical significance (p < 0.05).